Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Africa, Asia, Europe, South America, and the United States of
America (USA).
The purpose of this study is to evaluate the effectiveness of secondary prophylactic
treatment with NovoSeven® in haemophilia A and B patients with inhibitors.